FDA.reportPublic FDA data

Gvoke PFS 1 MG in 0.2 mL Pre-Filled Syringe

RxCUI
2199316
RxNorm name
Gvoke PFS 1 MG in 0.2 mL Pre-Filled Syringe
Display name
Gvoke PFS 1 MG in 0.2 mL Pre-Filled Syringe
Full name
Gvoke PFS 1 MG in 0.2 mL Pre-Filled Syringe
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
92385737-dbad-98c5-e053-2995a90a2805Gvoke PFS 1 MG in 0.2 mL Pre-Filled Syringe [PSN] · 0.2 ML glucagon 5 MG/ML Prefilled Syringe [Gvoke] [SBD] · 0.2 ML Gvoke 5 MG/ML Prefilled Syringe [SY] · Gvoke PFS 1 MG per 0.2 mL Pre-Filled Syringe [SY]420These highlights do not include all the information needed to use GVOKE and GVOKE VialDx safely and effectively. See full prescribing information for GVOKE and GVOKE VialDx. GVOKE (glucagon) injection, for subcutaneous use GVOKE VialDx (glucagon) injection, for intravenous use Initial U.S. Approval: 196020251223